psychotic disorder

Search with Google Search with Bing
Information
Disease name
psychotic disorder
Disease ID
DOID:2468
Description
"A cognitive disorder that involves abnormal thinking and perceptions resulting in a disconnection with reality." [url:http\://www.nlm.nih.gov/medlineplus/psychoticdisorders.html]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT00249119 Completed Phase 3 A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol in Patients With Chronic Schizophrenia December 1991
NCT00001656 Completed Phase 4 Comparison of Clozapine vs Olanzapine in Childhood-Onset Psychotic Disorders June 1997 June 2008
NCT00005658 Completed Phase 2 Glycine to Treat Psychotic Disorders in Children May 2000 January 2002
NCT01207219 Completed N/A Yoga and Aerobic Exercise in Psychosis November 2010 October 2014
NCT01279213 Completed Phase 4 Clozapine/Paliperidone Versus Clozapine/Placebo in Resistant Schizophrenia January 2009 December 2009
NCT01473550 Completed N/A Mental Health Engagement Network (MHEN) November 2011 June 2014
NCT01964404 Completed Phase 1 Cannabis, Schizophrenia and Reward: Self-Medication and Agonist Treatment? July 2014 September 18, 2021
NCT01995864 Completed N/A Critical Time Intervention-Task Shifting: Randomized Controlled Trial February 2014 June 1, 2020
NCT02306551 Completed Well Being And Resilience: Mechanisms of Transmission of Health and Risk September 2014 September 2021
NCT02399020 Completed N/A Social Cognition and Interaction Training for Adults With Psychotic Disorders: An Open Pilot Study in Finland January 2011 May 2013
NCT02958007 Completed N/A Peer Support for Exercise in Older Veterans With Psychotic Disorders June 1, 2018 May 31, 2022
NCT03483701 Completed N/A Thinking Skills at Work: Cognitive Remediation Therapy for Patients With Serious Mental Illness April 1, 2017 May 25, 2020
NCT03667729 Completed N/A The Effects of Progressive Muscle Relaxation Therapy in Patients With Schizophrenia June 30, 2014 June 29, 2015
NCT03688009 Completed N/A Mindfulness-Based Family Psychoeducation Intervention for Early Psychosis January 1, 2019 December 30, 2022
NCT03955250 Completed N/A Mobile After-Care Support App: Pilot RCT May 31, 2019 May 31, 2022
NCT04968275 Completed N/A A Cannabis Harm Reduction e-Intervention for Young Cannabis Users With Early Psychosis August 23, 2021 October 24, 2023
NCT00095524 Completed Phase 3 Effects of Aripiprazole in Overweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective Disorder March 2004 August 2006
NCT00137280 Completed N/A Implementing Effective, Collaborative Care for Schizophrenia (EQUIP-2) June 13, 2007 May 31, 2011
NCT00156715 Completed Phase 4 Efficacy of Quetiapine in the Treatment of Patients With Schizophrenia and a Comorbid Substance Use Disorder March 2004 October 2008
NCT00199940 Completed Phase 4 Safety And Efficacy Study Of Ziprasidone In Pediatric Psychotic Illness December 2003 April 2007
NCT00001482 Completed Phase 2 New Drugs in the Treatment of Mood Disorders May 1995 May 2001
NCT00287352 Completed Phase 1 Study of Amantadine for Weight Stabilization During Olanzapine Treatment May 2005 September 2009
NCT00350311 Completed Phase 2 Multicomponent Risk Factor Intervention for People With a Severe Mental Illness: a Feasibility Study February 2007 April 2008
NCT00350493 Completed Three Year Follow up of a Randomised Controlled Trial (RCT) of an Intervention for Tobacco Dependence Among Those With a Psychotic Illness January 2005 February 2006
NCT00397033 Completed Phase 3 Evaluation of Effectiveness and Safety of Paliperidone Extended Release in Patients With Schizoaffective Disorder. November 2006 February 2008
NCT00412373 Completed Phase 3 Evaluation of Effectiveness and Safety of Flexible-dose Paliperidone Extended Release in Patients With Schizoaffective Disorder. December 2006 June 2008
NCT00498550 Completed Phase 4 Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Treatment-as-Usual October 2000 March 2009
NCT00579267 Completed Reliability and Validity of the MINI International Neuropsychiatric Interview for Children and Adolescents (MINI-KID) February 2004 January 2008
NCT00716755 Completed N/A Minimizing Doses of Antipsychotic Medication in Older Patients With Schizophrenia. October 2009 August 2015
NCT00946348 Completed Phase 1 Cannabis and Schizophrenia: Self-Medication and Agonist Treatment December 2009 October 2012
NCT05440955 Not yet recruiting N/A tDCS for Cognitive Impairment Associated With Recent-onset Schizophrenia June 1, 2023 June 1, 2027
NCT05707689 Recruiting N/A The Impact of Gaming on Functioning Among People With Schizophrenia February 6, 2023 January 30, 2025
NCT06207526 Recruiting N/A Delusion Ideation in the Context of Everyday Life April 6, 2023 August 31, 2024
NCT04945278 Recruiting N/A Study of Self-Recognition and Self/Other Distinction Disorders in Patients With Psychological Vulnerability May 31, 2022 July 31, 2027
NCT03671005 Terminated N/A Mindfulness-based Group Therapy for Inpatients With Schizophrenia Spectrum Disorders May 1, 2018 February 28, 2021
NCT00169026 Terminated Phase 4 Alcoholism and Schizophrenia: Effects of Clozapine May 1999 January 2004
NCT04140773 Terminated N/A The Effect of D-serine as add-on Therapy in Recent-onset Psychosis November 25, 2021 August 31, 2022
NCT00232349 Terminated Phase 4 Efficacy of Galantamine to Treat Schizophrenia February 2005 June 2007
NCT00049738 Terminated Screening for Childhood-Onset Psychotic Disorders October 29, 2002 October 5, 2017
NCT00627029 Unknown status N/A Evaluation of Programs of Coordinated Care and Disease Management September 2000 December 2016
NCT05288049 Unknown status N/A Treating Early Stages With an Intervention Targeting Cognitive Reserve January 1, 2021 January 2023
NCT03414151 Unknown status Gut Microbiome in AP Naive February 7, 2018 March 2022
NCT01724372 Withdrawn N/A The Role of Antidepressants or Antipsychotics in Preventing Psychosis October 2012 May 2014
Disase is a (Disease Ontology)
DOID:1561
Cross Reference ID (Disease Ontology)
EFO:0000677
Cross Reference ID (Disease Ontology)
ICD9CM:298.8
Cross Reference ID (Disease Ontology)
UMLS_CUI:C0029516
Exact Synonym (Disease Ontology)
mental or behavioural disorder